down arrow

Sequent Scien.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
136.75
4.65 (3.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

134.25139.10

52 Week

91.85240.90
Valuation
Technical
Day's Volume

CASH

3.59 lacs (-39.27%) Volume

Shareholding (Dec 2024)

FII

6.10%

Held by 53 FIIs

DII

12.02%

Held by 14 DIIs

Promoter

52.61%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -6.95% CAGR growth in Operating Profits over the last 5 years

  • The company has been able to generate a Return on Equity (avg) of 5.10% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 3,423 Cr (Small Cap)

stock-summary
P/E

188.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.61

stock-summary
Return on Equity

2.86%

stock-summary
Price to Book

4.87

Revenue and Profits (1 Year):
Net Sales:
391 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.33%
0%
-28.33%
1 Year
8.27%
0%
8.27%
2 Years
85.57%
0%
85.57%
3 Years
-8.38%
0%
-8.38%
4 Years
-49.03%
0.19%
-48.84%
5 Years
73.54%
0.60%
74.14%

Latest dividend: 0.5 per share ex-dividend date: Sep-08-2021

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
-6.95%
EBIT to Interest (avg)
2.26
Debt to EBITDA (avg)
9.71
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.27
Tax Ratio
24.45%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.11%
ROCE (avg)
6.90%
ROE (avg)
5.10%
Valuation key factors
Factor
Value
P/E Ratio
188
Industry P/E
33
Price to Book Value
4.87
EV to EBIT
45.94
EV to EBITDA
25.18
EV to Capital Employed
3.40
EV to Sales
2.46
PEG Ratio
1.42
Dividend Yield
NA
ROCE (Latest)
6.42%
ROE (Latest)
2.86%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (9.58%)

FIIs

Held by 53 FIIs (6.1%)

Promoter with highest holding

Ca Harbor Investments (52.61%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (9.04%)

Individual Investors Holdings

23.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.66% vs -12.24% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -58.40% vs 193.24% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "390.81",
          "val2": "329.36",
          "chgp": "18.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.50",
          "val2": "22.25",
          "chgp": "55.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.95",
          "val2": "12.58",
          "chgp": "18.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.31",
          "val2": "2.76",
          "chgp": "-111.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.44",
          "val2": "8.27",
          "chgp": "-58.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.83%",
          "val2": "6.76%",
          "chgp": "2.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 11.73% vs 0.04% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 121.10% vs -130.93% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "758.86",
          "val2": "679.18",
          "chgp": "11.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "81.05",
          "val2": "6.90",
          "chgp": "1,074.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "30.67",
          "val2": "23.06",
          "chgp": "33.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.32",
          "val2": "-15.44",
          "chgp": "72.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.12",
          "val2": "-43.23",
          "chgp": "121.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.68%",
          "val2": "1.02%",
          "chgp": "9.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.99% vs -4.33% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 135.93% vs -26.71% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,149.67",
          "val2": "1,008.54",
          "chgp": "13.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "115.55",
          "val2": "29.15",
          "chgp": "296.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "45.62",
          "val2": "35.64",
          "chgp": "28.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.63",
          "val2": "-12.68",
          "chgp": "63.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.56",
          "val2": "-34.96",
          "chgp": "135.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.05%",
          "val2": "2.89%",
          "chgp": "7.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -3.60% vs 0.57% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 70.39% vs -395.80% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,369.73",
          "val2": "1,420.91",
          "chgp": "-3.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.41",
          "val2": "11.95",
          "chgp": "413.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "48.09",
          "val2": "35.52",
          "chgp": "35.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-17.39",
          "val2": "-64.79",
          "chgp": "73.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-35.88",
          "val2": "-121.16",
          "chgp": "70.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.48%",
          "val2": "0.84%",
          "chgp": "3.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
390.81
329.36
18.66%
Operating Profit (PBDIT) excl Other Income
34.50
22.25
55.06%
Interest
14.95
12.58
18.84%
Exceptional Items
-0.31
2.76
-111.23%
Consolidate Net Profit
3.44
8.27
-58.40%
Operating Profit Margin (Excl OI)
8.83%
6.76%
2.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 18.66% vs -12.24% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -58.40% vs 193.24% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
758.86
679.18
11.73%
Operating Profit (PBDIT) excl Other Income
81.05
6.90
1,074.64%
Interest
30.67
23.06
33.00%
Exceptional Items
-4.32
-15.44
72.02%
Consolidate Net Profit
9.12
-43.23
121.10%
Operating Profit Margin (Excl OI)
10.68%
1.02%
9.66%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 11.73% vs 0.04% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 121.10% vs -130.93% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,149.67
1,008.54
13.99%
Operating Profit (PBDIT) excl Other Income
115.55
29.15
296.40%
Interest
45.62
35.64
28.00%
Exceptional Items
-4.63
-12.68
63.49%
Consolidate Net Profit
12.56
-34.96
135.93%
Operating Profit Margin (Excl OI)
10.05%
2.89%
7.16%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.99% vs -4.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 135.93% vs -26.71% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,369.73
1,420.91
-3.60%
Operating Profit (PBDIT) excl Other Income
61.41
11.95
413.89%
Interest
48.09
35.52
35.39%
Exceptional Items
-17.39
-64.79
73.16%
Consolidate Net Profit
-35.88
-121.16
70.39%
Operating Profit Margin (Excl OI)
4.48%
0.84%
3.64%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -3.60% vs 0.57% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 70.39% vs -395.80% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sequent Scientific Ltd stock-summary
stock-summary
Sequent Scientific Ltd
Small Cap
Pharmaceuticals & Drugs
Sequent Scientific Limited was originally incorporated in the name of 'P I Drugs & Pharmaceuticals Limited' on June 28, 1995. The Company name was changed from 'P I Drugs & Pharmaceuticals Limited' to 'Sequent Scientific Limited' on October 27, 2009. The Company is a leading integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (APIs and finished dosage formulations) and analytical services.
Company Coordinates stock-summary
Company Details
301 Dosti Pinnacle 3rd Floor, Plot E7 Road No 22 Wagle Indl Thane Maharashtra : 400604
stock-summary
Tel: 91-022-41114777
stock-summary
http://www.sequent.in
stock-summary
investors@sequent.in
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."